JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Clinical trial NCT00239681 · TERMINATED

Trial details

NCT number: NCT00239681
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Elevated High-sensitivity C-Reactive Protein (hsCRP)

Start date: 2003-02-01
Primary completion: 2008-09-01
Enrollment: 17802

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.